Article Details

Semaglutide cuts death rates from cardiovascular disease and COVID-19 - News-Medical

Retrieved on: 2024-08-31 22:43:52

Tags for this article:

Click the tags to see associated articles and topics

Semaglutide cuts death rates from cardiovascular disease and COVID-19 - News-Medical. View article details on hiswai:

Excerpt

The randomized, controlled SELECT Trial, funded by Novo Nordisk, studied the effect of once-weekly semaglutide shots versus placebo on mortality in ...

Article found on: www.news-medical.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo